Foundry Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-699
Closed -$203K 438
2020
Q2
$203K Buy
+699
New +$203K 0.01% 380
2016
Q4
Sell
-10,261
Closed -$895K 451
2016
Q3
$895K Buy
10,261
+2,736
+36% +$239K 0.05% 308
2016
Q2
$647K Sell
7,525
-1,065
-12% -$91.6K 0.04% 308
2016
Q1
$683K Sell
8,590
-33,895
-80% -$2.7M 0.07% 197
2015
Q4
$5.35M Buy
+42,485
New +$5.35M 0.44% 80